These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 8694207

  • 21. Predilution versus postdilution continuous venovenous hemofiltration: no effect on filter life and azotemic control in critically ill patients on heparin.
    Nurmohamed SA, Jallah BP, Vervloet MG, Beishuizen A, Groeneveld AB.
    ASAIO J; 2011; 57(1):48-52. PubMed ID: 21084966
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Myoglobin clearance with continuous veno-venous hemodialysis using high cutoff dialyzer versus continuous veno-venous hemodiafiltration using high-flux dialyzer: a prospective randomized controlled trial.
    Weidhase L, de Fallois J, Haußig E, Kaiser T, Mende M, Petros S.
    Crit Care; 2020 Nov 11; 24(1):644. PubMed ID: 33176824
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Pharmacokinetics of levofloxacin during continuous veno-venous hemofiltration.
    Hansen E, Bucher M, Jakob W, Lemberger P, Kees F.
    Intensive Care Med; 2001 Feb 11; 27(2):371-5. PubMed ID: 11396281
    [Abstract] [Full Text] [Related]

  • 30. Effects of different doses in continuous veno-venous hemofiltration on plasma lactate in critically ill patients.
    Liu Y, Ouyang B, Chen J, Chen M, Ma J, Wu J, Huang S, Li L, Liu Z, Guan X.
    Chin Med J (Engl); 2014 Feb 11; 127(10):1827-32. PubMed ID: 24824239
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. A comparison of molecular clearance rates during continuous hemofiltration and hemodialysis with a novel volumetric continuous renal replacement system.
    Jeffrey RF, Khan AA, Prabhu P, Todd N, Goutcher E, Will EJ, Davison AM.
    Artif Organs; 1994 Jun 11; 18(6):425-8. PubMed ID: 8060251
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Solute clearance in CRRT: prescribed dose versus actual delivered dose.
    Lyndon WD, Wille KM, Tolwani AJ.
    Nephrol Dial Transplant; 2012 Mar 11; 27(3):952-6. PubMed ID: 21896498
    [Abstract] [Full Text] [Related]

  • 36. Evaluation of urea and creatinine change during continuous renal replacement therapy: effect of blood flow rate.
    Fealy N, Aitken L, du Toit E, Bailey M, Baldwin I.
    Crit Care Resusc; 2018 Mar 11; 20(1):41-47. PubMed ID: 29458320
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.